top
Search terms
Results 1 - 10 of 10 - ordered by :
Escardio

While the investigator-initiated study showed that DAPT (a combination of aspirin and the P2Y12-receptor blocker clopidogrel) does not decrease the rate of major adverse cardiovascular and ...

Date : 31/08/2015
Escardio

OSLER-1 and OSLER-2 Clinical Trials Evolocumab, a monoclonal antibody that inhibits pro-protein convertase subtilisin-kexin type 9 (PCSK9), significantly reduced low-density lipoprotein (LDL) ...

Date : 21/10/2015
Escardio

Amsterdam, The Netherlands, 1 September 2013 - Among patients undergoing percutaneous coronary intervention (PCI) with stents, the risk of cardiovascular complications after stopping dual ...

Date : 01/09/2013
Escardio

Results of the NIPPON (NoborI dual antiplatelet therapy as aPPrOpriate DuratioN) study, presented at ESC Congress 2016, showed similar rates of “net adverse clinical and cerebrovascular ...

Date : 28/08/2016
Escardio

Stockholm, Sweden, 30 August: Results from the LESSON I trial presented today provide preliminary evidence for the therapeutic benefit of the newer generation everolimus-eluting stent over the ...

Date : 30/08/2010
Escardio

The therapeutic benefit of revascularisation in coronary artery disease (CAD) is emphasised in the 2014 ESC/EACTS revascularisation guidelines presented at ESC Congress by joint Task Force Chairs ...

Date : 30/08/2014
Escardio

Sophia Antipolis, 9 January 2012: A registry -which includes every patient in Sweden having percutaneous coronary intervention (PCI) for the treatment of acute and stable coronary artery disease- has ...

Date : 06/01/2012
Escardio

[...]the PROlonging Dual antiplatelet treatment after Grading stent-induced Intimal hyperplasia studY (PRODIGY) also found a consistently greater risk of haemorrhage in the 24-month dual therapy ...

Date : 30/08/2011
Escardio

EMBARGO : 31 August 2015 at 14:30 BST “Coronary artery disease and acute coronary syndromes are the cause of death and disability in many patients,” said Dr Raban Jeger, interventional ...

Date : 31/08/2015
Escardio

Stockholm, Sweden, 29 August: Antithrombotic therapy using antiplatelet and anticoagulant agents is the cornerstone of treatment for acute and chronic coronary artery disease (CAD), yet it is also ...

Date : 29/08/2010